跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
顏 秀儒
主治醫師
,
臺北醫學大學附設醫院
https://orcid.org/0000-0003-1181-3253
電子郵件
b202093069
tmu.edu
tw
h-index
91
引文
6
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2007
2024
每年研究成果
概覽
指紋
網路
研究成果
(16)
類似的個人檔案
(6)
指紋
查看啟用 Hsiu-Ju Yen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Brain Tumor
96%
Peripheral Blood Stem Cell
96%
Hematopoietic Stem Cell
96%
Cell Count
67%
Peripheral Blood Stem Cell Collection
57%
Radiation Therapy
54%
Toddlers
53%
Childhood Cancer
51%
Pediatrics
51%
Germinoma
48%
Germ Line
48%
Stem Cell Mobilization
48%
Overdentures
48%
Sciatica
48%
Edentulousness
48%
Thiotepa
48%
Cell Lineage
48%
Second Cancer
48%
Spinal Cord Tumor
48%
Alternative Donor
48%
Minimal Residual Disease
48%
Stem Cell Therapy
48%
Aplastic Anemia
48%
Transplantation
48%
Body Weight
48%
Radiation Exposure
48%
Pediatric Cancer
48%
Pediatrics Patient
39%
Dentigerous Cyst
38%
Cancer
33%
Neoplasm
32%
Mononuclear Cell
28%
Central Nervous System
28%
Posterior Pituitary
28%
Prognostic Factor
26%
Magnetic Resonance Imaging
25%
Survival Rate
25%
Implant
24%
Graft Failure
24%
Hematopoietic Stem Cell Transplantation
24%
Autologous Peripheral Blood Stem Cell Transplantation
24%
Cancer Therapy
24%
Intensive Care Unit
24%
Intensive Care
24%
Granulocyte Colony Stimulating Factor
24%
Host Factor
24%
Stem Cell
24%
Tumor Marker
19%
Basal Ganglia
19%
Immunology and Microbiology
Peripheral Blood Stem Cell
96%
Hematopoietic Stem Cell
80%
CD34
76%
Cell Count
51%
Ossification
48%
Decision Trees
48%
Molecular Weight
48%
Transplant Procedure
48%
Animal Experiment
48%
Hypersensitive Response
48%
Escherichia coli
48%
Event Free Survival
48%
Overall Survival
41%
Erwinia
34%
Body Weight
32%
Mononuclear Cell
28%
Tree
28%
Multiplex Ligation Dependent Probe Amplification
24%
RNA Sequence
24%
Survival Rate
24%
T Cell
24%
Leporidae
19%
Computer Assisted Tomography
19%
Autologous Peripheral Blood Stem Cell Transplantation
15%
Host Factor
15%
Stem Cell
15%
Granulocyte Colony-Stimulating Factor
15%
Engraftment
10%
Drug Megadose
9%
Chemical Structure
9%
Magnetism
9%
Bone Regeneration
9%
Gamma Radiation
9%
Bone Conduction
9%
Cyclophosphamide
9%
Progression Free Survival
5%
Conditioning
5%
Stem Cell Transplant
5%
Biochemistry, Genetics and Molecular Biology
DUX4
64%
RNA Sequence
63%
T Cell
63%
Genetics
48%
MEF2D
48%
Drug Megadose
48%
Myeloid
48%
Low Drug Dose
48%
Reverse Transcription Polymerase Chain Reaction
48%
B Cell
48%
Clinical Trial
32%
Event Free Survival
32%
ETV6
31%
KMT2A
31%
RUNX1
31%
STIL
15%
Multiplex Ligation-Dependent Probe Amplification
15%
Survival Rate
15%
Flow Cytometry
15%
Overall Survival
15%
TAL1
15%
PAX5
15%
Gene Amplification
15%
Cytogenetics
15%
Dasatinib
15%
